Oxford Science Enterprises

Oxford Science Enterprises accounts for 17 tracked companies with verified cap-table data, 17 of which disclose round sizes totalling $3.1B. The median disclosed raise is $100M, and the largest is Oxford Ionics at $1.1B, ahead of AGTC ($290M) and Beacon Therapeutics ($290M).

The names that recur most often on these portfolio cap tables are Oxford Science Enterprises (17 companies), Lansdowne Partners (3 companies), Syncona (3 companies), Parkwalk Advisors (3 companies), Oxford Sciences Innovation (3 companies), Braavos Investment Advisers (2 companies). By latest disclosed round, the market skews Series B (10), Series A (5), Series C (2).

• Companies tracked: 17
• Disclosed funding total: $3.1B across 17 companies
• Median disclosed raise: $100M
• Largest raise: Oxford Ionics — $1.1B
• Stage mix: Series B 10 · Series A 5 · Series C 2
• Most recent dated round: 2026-05-01

Best funded Oxford Science Enterprises companies

1. Oxford Ionics — $1.1B (latest: Series A)
2. AGTC — $290M (latest: Series B)
3. Beacon Therapeutics — $290M (latest: Series B)
4. Quantum Motion — $251M (latest: Series C)
5. Osler Diagnostics — $170M (latest: Series C)
6. OMass Technologies — $160M (latest: Series B)
7. Grey Wolf Therapeutics — $131M (latest: Series B)
8. ONI — $100M (latest: Series B)
9. Amber Therapeutics — $100M (latest: Series A)
10. MoA Technology — $100M (latest: Series B)
11. Alloyed — $99M (latest: Series B)
12. Sitryx Therapeutics — $75M (latest: Series B)
13. PQShield — $65M (latest: Series B)
14. Wild Bioscience — $60M (latest: Series A)
15. Mind Foundry — $44M (latest: Series B)

Oxford Science Enterprises — related firms and companies (56)

• Oxford Ionics
• AGTC
• Beacon Therapeutics
• Quantum Motion
• Osler Diagnostics
• OMass Technologies
• Grey Wolf Therapeutics
• ONI
• Investors like Blockchain Capital
• Wild Bioscience
• Investors like Tiger Global Management
• Investors like Canaan Partners
• Investors like Vine Ventures
• Investors like HSG
• Investors like Fika Ventures
• Scenic Biotech
• Investors like Forerunner
• Investors like N47
• Investors like Foundry Group
• Investors like Floodgate
• Amber Therapeutics
• Oxford Science Enterprises co-investors 2026
• Investors like Western Technology Investment
• Investors like DCVC
• Investors like 500 Global
• Investors like Bessemer Venture Partners
• Alloyed
• Companies backed by Oxford Science Enterprises
• Investors like Draper Associates
• Investors like Accel
• Investors like Salesforce Ventures
• Investors like Peak XV Partners
• PQShield
• Investors like Balderton Capital
• Investors like Maven Ventures
• Investors like Contour Venture Partners
• Investors like International Finance Corporation
• Investors like Wellington Management
• Mind Foundry
• Investors like Thrive Capital
• Investors like Scale Venture Partners
• Investors like Upfront Ventures
• Investors like First Round Capital
• Investors like Oak HC/FT
• Theolytics
• Investors like Correlation Ventures
• Investors like Kleiner Perkins
• Investors like Canapi Ventures
• Investors like Bling Capital
• MoA Technology
• Investors like Oxford Science Enterprises
• Investors like Trinity Ventures
• Investors like Primary Venture Partners
• Investors like Accomplice
• Investors like Sapphire Ventures
• Sitryx Therapeutics

Oxford Science Enterprises alternatives · All research reports